Nutex Health regains Nasdaq minimum bid price compliance after reverse stock split

Nutex Health Inc.

Received compliance notice from Nasdaq on July 24, 2024.
Reverse stock split (1:10) effective July 3, 2024 lifted bid price above $1.00.
Closing bid price remained above $1.00 from July 3 through July 23, 2024.
Nasdaq Hearing Panel determined to continue listing of common stock (NUTX).
Matter closed; company avoids delisting risk under Rule 5550(a)(2).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.